We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
HYALASE hyaluronidase 1500IU powder for injection ampoule, Sanofi-Aventis Australia Pty Ltd , CON-785
Product name
HYALASE hyaluronidase 1500IU powder for injection ampoule
Sponsor name
Sanofi-Aventis Australia Pty Ltd
Batches
PVR10170, PWR10001 and PWR10002
Consent start
Consent no.
CON-785
Duration
The consent is effective from 14 May 2021 until 31 December 2021.
Standard
The European Pharmacopeia test for Loss on Drying (LOD) specification
Non-compliance with standard
The European Pharmacopeia test for Loss on Drying (LOD) specification, which is
LOD ? 5.0%.
Conditions imposed
This exemption only applies to drug substance batches PVR10170, PWR10001 and
PWR10002, as specified in the request.
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines